Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 14 | 2024 | 636 | 6.980 |
Why?
|
| Stroke Volume | 8 | 2024 | 349 | 1.940 |
Why?
|
| Heart-Assist Devices | 3 | 2019 | 25 | 1.460 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 18 | 1.310 |
Why?
|
| Clinical Trials as Topic | 3 | 2024 | 300 | 1.210 |
Why?
|
| Patient Participation | 2 | 2017 | 82 | 1.130 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 485 | 0.880 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 18 | 0.850 |
Why?
|
| Humans | 23 | 2024 | 32025 | 0.850 |
Why?
|
| Cardiovascular Agents | 1 | 2022 | 23 | 0.840 |
Why?
|
| Quality of Life | 3 | 2023 | 933 | 0.830 |
Why?
|
| Hemodynamics | 3 | 2019 | 155 | 0.810 |
Why?
|
| Furosemide | 1 | 2022 | 9 | 0.810 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 170 | 0.800 |
Why?
|
| Life Style | 1 | 2023 | 408 | 0.740 |
Why?
|
| Exercise | 2 | 2023 | 672 | 0.630 |
Why?
|
| Health Behavior | 1 | 2017 | 231 | 0.520 |
Why?
|
| Ventricular Function, Left | 3 | 2023 | 243 | 0.520 |
Why?
|
| Hospitalization | 3 | 2022 | 470 | 0.500 |
Why?
|
| Aged | 8 | 2024 | 10340 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1428 | 0.460 |
Why?
|
| Echocardiography | 2 | 2024 | 158 | 0.430 |
Why?
|
| Diuretics | 2 | 2023 | 26 | 0.430 |
Why?
|
| Aftercare | 2 | 2023 | 33 | 0.420 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 105 | 0.400 |
Why?
|
| Heart Rate | 2 | 2022 | 334 | 0.360 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 4 | 0.350 |
Why?
|
| Middle Aged | 6 | 2024 | 11868 | 0.350 |
Why?
|
| Prognosis | 2 | 2022 | 1505 | 0.310 |
Why?
|
| Female | 7 | 2024 | 19954 | 0.290 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3523 | 0.280 |
Why?
|
| Patient Discharge | 3 | 2023 | 188 | 0.270 |
Why?
|
| Eligibility Determination | 1 | 2024 | 18 | 0.240 |
Why?
|
| Treatment Outcome | 3 | 2022 | 3317 | 0.230 |
Why?
|
| Male | 6 | 2024 | 19196 | 0.230 |
Why?
|
| Exercise Therapy | 2 | 2023 | 270 | 0.230 |
Why?
|
| Tissue Engineering | 1 | 2009 | 656 | 0.230 |
Why?
|
| Cohort Studies | 2 | 2019 | 1831 | 0.230 |
Why?
|
| Heart Transplantation | 1 | 2023 | 27 | 0.220 |
Why?
|
| Risk Factors | 3 | 2021 | 3869 | 0.220 |
Why?
|
| Digoxin | 1 | 2022 | 4 | 0.210 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 15 | 0.210 |
Why?
|
| Neprilysin | 1 | 2022 | 31 | 0.210 |
Why?
|
| Sodium | 1 | 2022 | 39 | 0.210 |
Why?
|
| Potassium | 1 | 2022 | 39 | 0.210 |
Why?
|
| Patient Selection | 1 | 2024 | 277 | 0.210 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 61 | 0.210 |
Why?
|
| Research Design | 1 | 2024 | 312 | 0.200 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 12 | 0.200 |
Why?
|
| Glucose | 1 | 2022 | 174 | 0.190 |
Why?
|
| Phenotype | 1 | 2023 | 639 | 0.190 |
Why?
|
| Electronic Health Records | 1 | 2022 | 162 | 0.190 |
Why?
|
| Hospital Mortality | 2 | 2019 | 198 | 0.180 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 82 | 0.180 |
Why?
|
| Disease Progression | 1 | 2022 | 594 | 0.180 |
Why?
|
| Benchmarking | 1 | 2019 | 23 | 0.170 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 2019 | 135 | 0.150 |
Why?
|
| Retirement | 1 | 2017 | 12 | 0.150 |
Why?
|
| Medically Uninsured | 1 | 2017 | 32 | 0.150 |
Why?
|
| Employment | 1 | 2017 | 49 | 0.150 |
Why?
|
| Educational Status | 1 | 2017 | 179 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 474 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2017 | 141 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 878 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2017 | 125 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 687 | 0.130 |
Why?
|
| United States | 2 | 2023 | 3938 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 663 | 0.130 |
Why?
|
| Logistic Models | 1 | 2017 | 781 | 0.130 |
Why?
|
| Obesity | 1 | 2022 | 1179 | 0.120 |
Why?
|
| Smoking | 1 | 2017 | 500 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 473 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1530 | 0.110 |
Why?
|
| Young Adult | 1 | 2017 | 2615 | 0.090 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 13 | 0.090 |
Why?
|
| Adolescent | 1 | 2017 | 3526 | 0.090 |
Why?
|
| Polymers | 1 | 2009 | 64 | 0.080 |
Why?
|
| Adult | 2 | 2018 | 9367 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 232 | 0.070 |
Why?
|
| Stem Cells | 1 | 2009 | 313 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 29 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2023 | 154 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 103 | 0.050 |
Why?
|
| Registries | 1 | 2023 | 298 | 0.050 |
Why?
|
| Medicare | 1 | 2023 | 207 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 507 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 518 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 97 | 0.040 |
Why?
|
| Animals | 1 | 2009 | 7466 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 200 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 4000 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1194 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 2152 | 0.030 |
Why?
|